← Leaderboards
Brook Henry
University Of California, San Diego
$8,903,411
Attributed
$13,805,561
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,805,561 · 8
By mechanism
R01$11,305,947 · 4
RF1$1,548,394 · 1
R21$849,012 · 2
F32$102,208 · 1
Top collaborators
- Ronald J. Ellis8 shared
- Scott L Letendre5 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Ronald J. Ellis$34,493,757
- Arpi Minassian$3,527,634
- Jared William Young$14,211,149
- Scott L Letendre$25,948,231
- Francesca Telese$9,328,049
Others in their field
Top investigators on “Neurocognitive”
- Sharon A Nachman · Johns Hopkins University$74,919,967
- Rose A Gubitosi-Klug · Case Western Reserve University$70,295,008
- Josef Coresh · New York University School Of Medicine$56,427,528
- Raquel E Gur · University Of Pennsylvania$52,547,700
- Michael S. Saag · University Of Alabama At Birmingham$50,481,750
- Deborah W Bruner · American College Of Radiology$47,328,736
Research focus
NeurocognitiveDesignCognitionParticipantReportingVisitMedicalAntiretroviral TherapyPerformanceCognitiveInflammationMonitorPersonsBiological MarkersEnzymesImpairmentExhibitsPlasmaPharmaceutical PreparationsMediatingImpaired CognitionDoseNeurocognitive DeficitPattern
Grant awards (24)
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV$1,548,394
RF1 · FY2025 · AG
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV$789,997
R01 · FY2024 · AG
Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$710,942
R01 · FY2024 · DA
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV$789,997
R01 · FY2023 · AG
Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$710,942
R01 · FY2023 · DA
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV$789,997
R01 · FY2022 · AG
Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$710,942
R01 · FY2022 · DA
Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$623,855
R01 · FY2021 · DA
Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$708,692
R01 · FY2020 · DA
Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain$594,681
R01 · FY2020 · DA · contact PI
iSTEP: an mHealth Physical Activity and Diet Intervention for Persons with HIV$547,463
R01 · FY2020 · NR · contact PI
iSTEP: an mHealth Physical Activity and Diet Intervention for Persons with HIV$616,432
R01 · FY2019 · NR · contact PI
Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain$602,874
R01 · FY2019 · DA · contact PI
iSTEP: an mHealth Physical Activity and Diet Intervention for Persons with HIV$617,610
R01 · FY2018 · NR · contact PI
Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain$604,788
R01 · FY2018 · DA · contact PI
Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain$618,199
R01 · FY2017 · DA · contact PI
iSTEP: an mHealth Physical Activity and Diet Intervention for Persons with HIV$614,053
R01 · FY2017 · NR · contact PI
iSTEP: an mHealth Physical Activity and Diet Intervention for Persons with HIV$654,483
R01 · FY2016 · NR · contact PI
Endocannabinoids, Cannabis, and Neurocognitive Deficits in HIV$229,012
R21 · FY2015 · DA · contact PI
Text Message Physical Activity Intervention to Treat Cognitive Deficits in HIV$193,750
R21 · FY2014 · MH · contact PI
Endocannabinoids, Cannabis, and Neurocognitive Deficits in HIV$193,750
R21 · FY2014 · DA · contact PI
Text Message Physical Activity Intervention to Treat Cognitive Deficits in HIV$232,500
R21 · FY2013 · MH · contact PI
Inhibitory Deficits in Bipolar Disorder and Methamphetamine Dependence$52,154
F32 · FY2010 · DA · contact PI
Inhibitory Deficits in Bipolar Disorder and Methamphetamine Dependence$50,054
F32 · FY2009 · DA · contact PI